Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-9 of 9 for your search:
Cancer Type:
Thyroid cancer
Stage/Subtype of Cancer:
stage II papillary thyroid cancer
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase II Study of Bortezomib in Patients With Metastatic Papillary or Follicular Thyroid Cancer Unresponsive to Prior Radioiodine Therapy
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MDA-2004-0059
, 6132, NCI-6132, NCT00104871
2.
Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
16 and over
Sponsor:
NIDDK
Protocol IDs:
060025
, 06-DK-0025, NCT00251316
3.
Phase II Study of Sunitinib Malate in Patients With Iodine I 131-Refractory, Unresectable Well-Differentiated Thyroid Cancer or Medullary Thyroid Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UCCRC-14696A
, 14696A, 7735, NCI-7735, NCT00381641
4.
Phase II Study of AZD6244 in Patients With Iodine I 131-Refractory Papillary Thyroid Carcinoma or Papillary Thyroid Carcinoma With Follicular Elements
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MCC-15305
, MCC-15305, MCC-LOI-7918, 7918, NCT00559949
5.
Phase II Study of Pazopanib Hydrochloride in Patients With Advanced Thyroid Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MAYO-MC057H
, MC057H, 7627, NCT00625846
6.
Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
04-116
, NCT00673010
7.
Study of Iodine I 131 Therapy in Patients With Thyroid Cancer
Phase:
No phase specified
Type:
Diagnostic, Treatment
Status:
Active
Age:
18 to 100
Sponsor:
NCI
Protocol IDs:
JHOC-J0628
, NCT00416949
8.
A Proof-of-Concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis
Phase:
No phase specified
Type:
Diagnostic, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
GE-135-003
, NCT00565721
9.
A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoind and Peroxisome-Proliferator-Activated Receptor (PPARy) Expression
Phase:
No phase specified
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
COMIRB# 07-0727
, NCT00718770
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute